Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.9204
-0.0283 (-2.98%)
At close: Jun 9, 2026, 4:00 PM EDT
0.9400
+0.0196 (2.13%)
After-hours: Jun 9, 2026, 7:37 PM EDT

Rein Therapeutics Stock Forecast

RNTX's stock price has decreased by -53.98% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Rein Therapeutics stock have an average target of $8.00, which predicts a 769.19% increase from the current stock price of 0.92.

Price Target: $8.00 (+769.19%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$8.00$8.00$8.00$8.00
Change+769.19%+769.19%+769.19%+769.19%

Analyst Ratings

The average analyst rating for Rein Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingSep '25Nov '25Jan '26Apr '26May '26Jun '26
Strong Buy021111
Buy100000
Hold101100
Sell000000
Strong Sell000000
Total222211

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$10$8
BuyReiterates$10$8+769.19%Jun 1, 2026
Brookline Capital Markets
Brookline Capital Markets
Hold
Downgrades
n/a
HoldDowngradesn/an/aJan 21, 2026

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.54
EPS Next Year
-0.54
from -0.54
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
------
Operating Income
-26.61M-27.65M-15.35M-28.11M-21.93M-32.10M
Net Income
-26.16M-27.33M-15.73M-62.88M-49.87M-32.10M
EPS
------0.54
Free Cash Flow
-13.50M-14.48M-7.62M-14.82M-11.37M-47.00M
No. Analysts
-----1
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-0.54
Avg-0.54
Low-0.54

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-